Market highlights

The preclinical imaging market is expected to reach USD 5.48 billion by 2030 at 3.20% CAGR during the forecast period 2023-2030.

Factors such as developments in molecular imaging technologies, growing consumer interest for non-invasive small-animal imaging approaches, and growing R&D investments to support preclinical research are slated to propel market growth. Preclinical micro-ultrasound technologies are being investigated for developmental genetics, cancer , and cardiovascular disease. The new advances in high-frequency ultrasonic imaging are still being established with respect to the future. The use of multiple imaging modalities for preclinical trials will help researchers understand the biological, genetic, and physiological changes in living animals and forecast the outcome of experimental therapies in patients. Consequently, the market is slated to see strong growth over the forecast period due to both of these factors. Furthermore, the steady pace of technological innovation that leads to the production of hybrid imaging systems is primarily driving global market growth. Moreover, the number of clinical research organizations (CROs) and pharmaceutical firms is the use of in-vivo imaging systems in preclinical testing, which accelerates further the development of this market.

Strict legislation in preclinical science, however, as well as high deployment and maintenance costs associated with preclinical imaging modalities impede market development over the poised period. In addition, the limitations imposed on animal testing due to laws implemented by organizations defending animal rights are the main factors impeding business development.

Segmental Analysis

The global preclinical imaging market has been analyzed based on the reagent, modality, and region.

The modality-based segmentation of the market comprises into optical imaging systems, nuclear imaging systems, micro-ultrasound, micro-MRI, photoacoustic imaging, micro-CT, and magnetic particle imaging. The field of optical imaging systems is predicted to continue its dominance over the market share as it recorded in 2017.

The reagent-based segmentation of the market comprises preclinical ultrasonic contrast agents, preclinical optical imaging reagents, preclinical MRI contrast agents, preclinical nuclear imaging reagents, and preclinical CT contrast agents. The field of preclinical optical imaging reagents is predicted to maintain its winning streak over the prognosis period.

Competitive Dashboard

The global preclinical imaging market players are Bruker Corporation (US), MR Solutions (UK), PerkinElmer Inc. (US), Fujifilm Holdings Corporation (Japan), Milabs B.V. (The Netherlands), Mediso Ltd. (Hungary), LI-COR, Inc. (US), Miltenyi Biotec GmbH (Germany), Aspect Imaging (Israel), and Trifoil Imaging (US).

Regional Overview

The Asia-Pacific preclinical imaging market is consists of developing economies like China, the Republic of Korea, India , Japan, Australia, and the rest of the Asia-Pacific region. The Asia-Pacific region is slated to be the region with the highest growth. the high demand for remote sensing services in various applications, such as precision farming, 3D terrain model building, damage evaluation, pipeline tracking, geohazard modeling, resource extraction, and security and intelligence is leading the Asia Pacific region market to secure the fastest CAGR.

Driven by growing investments in numerous military and commercial satellite projects, North America is second to the European market in the demand for remote sensing satellites. The North American industry is powered primarily by an growing need for remote sensing services in diverse industries and the presence of major public and private companies.

Europe is slated to hold the second-largest regional growth in the global market for preclinical imaging. The growing success of this region's demand is resulting in further R&D investments towards the promotion of preclinical research. On the other hand, the Middle East & Africa is observing gradual growth and is slated to acquire for the lowest market share of the preclinical imaging market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com